EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Haemonetics Corporation (HAE) EBITDA Margin data is not available.
| Income Statement Financials | |
$330.60M |
|
$57.98M |
|
$137.55M |
|
$193.05M |
|
$259.26M |
|
$71.33M |
|
$-0.60M |
|
$70.74M |
|
$70.74M |
|
$57.98M |
|
$57.98M |
|
$57.98M |
|
$57.98M |
|
$71.33M |
|
$102.18M |
|
50.33M |
|
50.73M |
|
$1.17 |
|
$1.17 |
|
| Balance Sheet Financials | |
$934.98M |
|
$284.05M |
|
$1.52B |
|
$2.45B |
|
$578.11M |
|
$921.23M |
|
$1.05B |
|
$1.63B |
|
$820.84M |
|
$-239.18M |
|
$820.84M |
|
48.22M |
|
| Cash Flow Statement Financials | |
$181.72M |
|
$-161.90M |
|
$108.82M |
|
$178.80M |
|
$306.76M |
|
$127.96M |
|
$29.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.62 |
|
-- |
|
-- |
|
0.53 |
|
1.49 |
|
58.39% |
|
21.58% |
|
21.58% |
|
|
EBITDA Margin |
-- |
21.40% |
|
17.54% |
|
$165.70M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.38 |
|
1.63 |
|
55.17 |
|
7.06% |
|
-24.24% |
|
2.37% |
|
3.33% |
|
$17.02 |
|
$3.27 |
|
$3.58 |
|